Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events
Acta neuropsychiatrica, 2023-02, Vol.35 (1), p.3-4 [Peer Reviewed Journal]The Author(s), 2023. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology ;ISSN: 0924-2708 ;EISSN: 1601-5215 ;DOI: 10.1017/neu.2023.3 ;PMID: 36600514
Full text available